Navigation Links
Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
Date:2/22/2010

> Subsequent Events

On February 15, 2010, the Company entered into an agreement with one of the holders of its convertible notes, Pope Investments LLC ("Pope"), whereby Pope agreed to waive certain provisions set forth in the November 2007 and May 2008 securities purchase agreements for the Company's debentures and convertible notes, provided that the Company has made the November 2009 interest payments to the holders of the Company's November 2007 debentures and May 2008 notes on or prior to February 25, 2010. If the interest payments are not made by February 25, 2010 all rights and remedies of Pope defined in the 2007 and 2008 Securities Purchase Agreements shall remain in full force and effect as if this waiver had not been granted.

The Company also agreed that in the event that its common stock has not been listed on the NASDAQ Stock Market on or prior to April 15, 2010, it will pay to the holders of the 2007 Notes and the 2008 Notes an amount equal to the difference between the interest on such Notes previously paid for the period from June 1, 2009 to November 30, 2009.


'/>"/>
SOURCE Jiangbo Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine technology :

1. Jiangbo Pharmaceuticals Osteomyelitis Treatment Tablets to be Included in Chinas National Insurance Directory
2. Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
3. Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for the First Quarter of Fiscal Year 2010
4. Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results
5. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... WORTH, Texas , May 22, 2015 ... $58.4 million in 2014 and is estimated to reach $90.7 ... to 2019. Browse through the TOC of North ... and segments, with the help of various tables and figures. ... will receive 10% customization on this report.   ...
(Date:5/22/2015)... and KING OF PRUSSIA, Pa. ... (NHF) has awarded CSL Behring its 2015 ... unwavering commitment to advancing science and improving the care of ... Paul Perreault , CEO and Managing Director, CSL Limited, during ... City on May 21. "The National ...
(Date:5/22/2015)... May 22, 2015 According to ... by Product (Consumables, Instruments, Services), by Test Type (Indirect, ... Flow Cytometry), by End Users - Global Forecast to ... is expected to reach $736.85 Million by 2020 from ... 10.25%. Browse 71 market data Tables ...
Breaking Medicine Technology:North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4
... N.J., Oct. 25, 2011 Omthera Pharmaceuticals, Inc., a ... J. Maines has joined the Company as Vice President ... to Chief Operating Officer, Drs. Ben Machielse, Mr. Maines ... at Omthera.   Mr. Maines brings to ...
... N.C., Oct. 25, 2011 GlaxoSmithKline, one of ... today announced the 10 winners of its GlaxoSmithKline ... Philadelphia-area healthcare nonprofit organizations will receive $400,000 in ... the underserved in their communities. Three ...
Cached Medicine Technology:Timothy J. Maines Joins Omthera Pharmaceuticals as Vice President of Quality 2GlaxoSmithKline to Grant $400,000 to Healthcare Nonprofits at Annual IMPACT Awards 2GlaxoSmithKline to Grant $400,000 to Healthcare Nonprofits at Annual IMPACT Awards 3
(Date:5/22/2015)... Wimbledon Health Partners, the leading on-site diagnostic ... NCV testing , is proud to announce the ... National athlete, to the Wimbledon Athletics division. , ... of testing and information it provides to be extremely ... this way they can focus on the task at ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 In an ... Parker and Sons is offering to donate $5 dollars ... an AC unit or water softening system. Customers have ... Parker and Sons gets business; and the Special Olympics ... The Special Olympics helps over 4.4 million athletes, and ...
(Date:5/22/2015)... Co founders Greenlee and James Chapko, DDS ... dentists to immediately deliver fully integrated dental implant services to ... the medical surgeon. , The Center, whose name is ... dentists from placing dental implants. These 6 roadblocks can ... the surgical placement of dental implants into his or her ...
(Date:5/22/2015)... Portland, Maine (PRWEB) May 22, 2015 ... in single-use swabs for the medical, diagnostic, environmental, ... their entire line of products in the US. ... moving their operations outside the US, Puritan remains ... of products at their Guilford, Maine facility. , ...
(Date:5/22/2015)... Javon Bea Mercy Health System : “It ... highest quality emergency care services, especially by women who ... R. Bea, President and CEO of Mercy Health System. ... care for and respond to what is most important ... this award, but are selected if they consistently rank ...
Breaking Medicine News(10 mins):Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2Health News:First of Its Kind Dental Implant Training and Surgicenter to Open in June 2Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2Health News:Mercy Hospital and Trauma Center Receives Women’s Choice Award for Emergency Care - Mercy Health System Javon Bea 2
... A major breakthrough in how to target and ... has been made by researchers at Wake Forest University ... way to target and destroy Glioblastoma multiforme (GBM) cells ... new possibilities in cancer research previously not known to ...
... have a big impact on the food you eat, the ... a report in a special section on Culture and Psychology ... the Association for Psychological Science, psychological scientists Denise C. Park ... from the University of Illinois at Urbana-Champaign discuss ways in ...
... biologist and mathematician have joined forces to find out ... hormone prolactin from the pituitary gland, research that could ... including infertility. Marc Freeman, the Lloyd M. ... Emeritus, and mathematics Professor Richard Bertram have received a ...
... Ill. Hand therapy is one of the most vital ... a literature review published in the August 2010 issue of ... (JAAOS). In fact, many patients spend more time with ... to ensure the best results and long-term recovery. "Hand ...
... Dotinga HealthDay Reporter , MONDAY, Aug. 2 (HealthDay ... fat? A new two-year study suggests that it may ... guidance about eating and exercise, people lost about the same ... diet or a traditional low-fat diet. "In general, dieters ...
... a single rock being overturned or an entire mountaintop ... processes, and vice versa. Ecological scientists will discuss findings ... growth to the diversity of insect species on green ... buildingsat the Ecological Society of America,s 95th Annual Meeting ...
Cached Medicine News:Health News:Scientists develop 'designer protein,' opening new door in cancer research 2Health News:Scientists develop 'designer protein,' opening new door in cancer research 3Health News:Culture wires the brain: A cognitive neuroscience perspective 2Health News:FSU study takes novel approach to understanding pituitary function 2Health News:FSU study takes novel approach to understanding pituitary function 3Health News:Keeping patients 'in good hands' 2Health News:Low Carb-, Low-Fat Diets Tied for Long-Term Weight Loss 2Health News:Low Carb-, Low-Fat Diets Tied for Long-Term Weight Loss 3Health News:Scientists unravel human-ecosystem interactions 2Health News:Scientists unravel human-ecosystem interactions 3Health News:Scientists unravel human-ecosystem interactions 4
QC 900 is an assayed quality control material for analyzers measuring hematocrit by electrical conductivity methodologies. It is available in two (2) levels for monitoring analyzer performance at var...
... an assayed quality control material ... of blood gas, electrolyte, metabolite, ... is available in three (3) ... at varying points within the ...
... control material that, once tonometered, is used ... electrolyte, metabolite, and CO-Oximeter instrumentation. It provides ... human blood in tonometry. QC 463 is ... analyzer performance at varying points within the ...
... QuantiGene 2.0 is a reagent and ... expression knockdown. The high throughput plate based ... assay that provides a unique approach for ... reporter signal using branched DNA (bDNA) technology. ...
Medicine Products: